144 related articles for article (PubMed ID: 1625347)
21. Effects of propionyl-L-carnitine in chronically hypoperfused ("hibernating") myocardium.
Bolukoglu H; Eggleston AM; Subramanian R; Nellis SH; Liedtke AJ
Cardioscience; 1991 Dec; 2(4):245-55. PubMed ID: 1760516
[TBL] [Abstract][Full Text] [Related]
22. The effect of propionyl-L-carnitine on the ischemic and reperfused intact myocardium and on their derived mitochondria.
Ferrari R; Ceconi C; Cargnoni A; Pasini E; Boffa GM; Curello S; Visioli O
Cardiovasc Drugs Ther; 1991 Feb; 5 Suppl 1():57-65. PubMed ID: 2031872
[TBL] [Abstract][Full Text] [Related]
23. Positive action of propionyl-L-carnitine on mechanical performance of papillary muscle from Syrian hamsters with hereditary dilated cardiomyopathy.
Maresca P; Mancinelli R; Corsico N; Arrigoni-Martelli E; Manni E
Eur J Pharmacol; 1995 Dec; 287(3):303-7. PubMed ID: 8991805
[TBL] [Abstract][Full Text] [Related]
24. Electrophysiological effects of EGIS-7229, a new antiarrhythmic agent, in isolated mammalian and human cardiac tissues.
Pankucsi C; Bányász T; Magyar J; Gyönös I; Kovács A; Varró A; Szénási G; Nánási PP
Naunyn Schmiedebergs Arch Pharmacol; 1997 Mar; 355(3):398-405. PubMed ID: 9089672
[TBL] [Abstract][Full Text] [Related]
25. Antiradical effects in L-propionyl carnitine protection of the heart against ischemia-reperfusion injury: the possible role of iron chelation.
Reznick AZ; Kagan VE; Ramsey R; Tsuchiya M; Khwaja S; Serbinova EA; Packer L
Arch Biochem Biophys; 1992 Aug; 296(2):394-401. PubMed ID: 1321584
[TBL] [Abstract][Full Text] [Related]
26. On the roles of long-chain acyl carnitine accumulation and impaired glucose utilization in ischaemic contracture development and tissue damage in the guinea-pig heart.
Clarke B; Wyatt KM; May GR; McCormack JG
J Mol Cell Cardiol; 1996 Jan; 28(1):171-81. PubMed ID: 8745225
[TBL] [Abstract][Full Text] [Related]
27. Propionyl-L-carnitine prevents myocardial mechanical alterations due to pressure overload in rats.
Micheletti R; Giacalone G; Canepari M; Salardi S; Bianchi G; Reggiani C
Am J Physiol; 1994 Jun; 266(6 Pt 2):H2190-7. PubMed ID: 8023981
[TBL] [Abstract][Full Text] [Related]
28. In vivo and in vitro intervention with L-carnitine prevents abnormal energy metabolism in isolated diabetic rat heart: chemical and phosphorus-31 NMR evidence.
Pieper GM; Murray WJ
Biochem Med Metab Biol; 1987 Aug; 38(1):111-20. PubMed ID: 3663394
[TBL] [Abstract][Full Text] [Related]
29. Electrophysiological effects of acetyl glyceryl ether phosphorylcholine on cardiac tissues: comparison with lysophosphatidylcholine and long chain acyl carnitine.
Nakaya H; Tohse N
Br J Pharmacol; 1986 Dec; 89(4):749-57. PubMed ID: 3814909
[TBL] [Abstract][Full Text] [Related]
30. Protective effects of propionyl-L-carnitine during ischemia and reperfusion.
Shug A; Paulson D; Subramanian R; Regitz V
Cardiovasc Drugs Ther; 1991 Feb; 5 Suppl 1():77-83. PubMed ID: 2031875
[TBL] [Abstract][Full Text] [Related]
31. Effect of propionyl-L-carnitine on the mechanics of right and left papillary muscles from volume-overloaded rat hearts.
Micheletti R; Giacalone G; Bianchi G
J Cardiovasc Pharmacol; 1996 Jan; 27(1):52-7. PubMed ID: 8656658
[TBL] [Abstract][Full Text] [Related]
32. Short term effects of intra-arterial propionyl-L-carnitine on isolated canine hind-limbs.
Cevese A; Schena F; Poltronieri R; Cerutti G
Cardioscience; 1995 Mar; 6(1):59-64. PubMed ID: 7605897
[TBL] [Abstract][Full Text] [Related]
33. The propionyl-L-carnitine hypothesis: an alternative approach to treating heart failure.
Ferrari R; De Giuli F
J Card Fail; 1997 Sep; 3(3):217-24. PubMed ID: 9330130
[TBL] [Abstract][Full Text] [Related]
34. Propionyl-L-carnitine effects on postischemic recovery of heart function and substrate oxidation in the diabetic rat.
Broderick TL; Driedzic W; Paulson DJ
Mol Cell Biochem; 2000 Mar; 206(1-2):151-7. PubMed ID: 10839205
[TBL] [Abstract][Full Text] [Related]
35. Electrophysiological and inotropic characterization of a novel class III antiarrhythmic agent, GLG-V-13, in the mammalian heart.
Fazekas T; Carlsson L; Scherlag BJ; Mabo P; Poty H; Palmer M; Patterson E; Berlin KD; Garrison GL; Lazzara R
J Cardiovasc Pharmacol; 1996 Aug; 28(2):182-91. PubMed ID: 8856472
[TBL] [Abstract][Full Text] [Related]
36. Free radical scavenging is involved in the protective effect of L-propionyl-carnitine against ischemia-reperfusion injury of the heart.
Packer L; Valenza M; Serbinova E; Starke-Reed P; Frost K; Kagan V
Arch Biochem Biophys; 1991 Aug; 288(2):533-7. PubMed ID: 1654837
[TBL] [Abstract][Full Text] [Related]
37. Positive inotropic effect of coenzyme Q10, omega-3 fatty acids and propionyl-L-carnitine on papillary muscle force-frequency responses of BIO TO-2 cardiomyopathic Syrian hamsters.
Vargiu R; Littarru GP; Faa G; Mancinelli R
Biofactors; 2008; 32(1-4):135-44. PubMed ID: 19096109
[TBL] [Abstract][Full Text] [Related]
38. Propionyl-L-carnitine improves hemodynamics and metabolic markers of cardiac perfusion during coronary surgery in diabetic patients.
Lango R; Smoleński RT; Rogowski J; Siebert J; Wujtewicz M; Słomińska EM; Lysiak-Szydłowska W; Yacoub MH
Cardiovasc Drugs Ther; 2005 Aug; 19(4):267-75. PubMed ID: 16187006
[TBL] [Abstract][Full Text] [Related]
39. Effect of propionyl-l-carnitine and enalapril on cardiac function of pressure-overloaded rats during increase in load.
Micheletti R; Donato di Paola E; Schiavone A; Rossi R; Bianchi G
Eur J Pharmacol; 1995 Nov; 286(2):147-54. PubMed ID: 8605951
[TBL] [Abstract][Full Text] [Related]
40. Changes in the subcellular distribution of free carnitine and its acyl derivatives in diabetic rat hearts following treatment with L-carnitine.
Aoshima S; Fujisawa S; Kobayashi A
Jpn Heart J; 1993 Nov; 34(6):763-72. PubMed ID: 8164344
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
